Vertex Pharmaceuticals
23 марта, 22:02

Top Research Reports for Oracle, Vale & General Mills

Top Research Reports for Oracle, Vale & General Mills

Выбор редакции
15 марта, 16:19

7 Things Vertex Pharmaceuticals' CEO Just Said That Will Probably Make You Want to Buy the Stock

The only "problem" mentioned by Vertex CEO Jeff Leiden? It's accumulating cash rapidly.

13 марта, 18:04

3 Biotech Stocks With Rising Earnings Estimates Post Q4

The biotech industry performed reasonably well in Q4. Hence, it is a good idea to select stocks from the sector which saw positive estimate revisions post Q4 earnings release.

12 марта, 22:20

Why Sarepta (SRPT) Jumped and We Sold

Why Sarepta (SRPT) Jumped and We Sold

28 февраля, 21:26

Biotech Stock Round Up: Celgene Suffers Setback, Gilead Teams Up with Sangamo

The major news in the biotech sector in the last five trading sessions include the FDA's refusal to file letter for Celgene Corporation's (CELG) ozanimod while Gilead Sciences, Inc.'s (GILD) announced an agreement with Sangamo Therapeutics.

21 февраля, 16:07

The Zacks Analyst Blog Highlights: Amgen, TOTAL, Marriott, PG&E and Vertex

The Zacks Analyst Blog Highlights: Amgen, TOTAL, Marriott, PG&E and Vertex

21 февраля, 00:58

Top Analyst Report for Amgen, TOTAL S.A. & Marriott

Top Analyst Report for Amgen, TOTAL S.A. & Marriott

Выбор редакции
17 февраля, 04:15

Vertex Pharmaceuticals Scores an Important Win

The company's 2018 financial outlook just got a bit better.

13 февраля, 18:35

Vertex's Third Cystic Fibrosis Treatment Gets FDA Approval

Vertex???s (VRTX) FDA approved tezacaftor/ivacaftor combination for cystic fibrosis in patients with certain mutations in the CFTR gene marks the indication???s third treatment.

08 февраля, 15:31

The Zacks Analyst Blog Highlights: Wells Fargo, Caterpillar, Schlumberger, Vertex and Republic Services

The Zacks Analyst Blog Highlights: Wells Fargo, Caterpillar, Schlumberger, Vertex and Republic Services

08 февраля, 00:17

Top Stock Reports for Wells Fargo, Caterpillar & Schlumberger

Top Stock Reports for Wells Fargo, Caterpillar & Schlumberger

07 февраля, 18:12

REGN vs. ALXN: Which Stock is Poised for Better Q4 Earnings?

Let's take a look at which of these biotech companies, Alexion (ALXN) or Regeneron (REGN) has an edge ahead of their Q4 release.

05 февраля, 17:46

The Zacks Analyst Blog Highlights: Sanofi, Seattle Genetics, AbbVie, Celgene and Vertex

The Zacks Analyst Blog Highlights: Sanofi, Seattle Genetics, AbbVie, Celgene and Vertex

Выбор редакции
02 февраля, 00:17

Vertex Pharmaceuticals Picks Between "Sirloin Steak and Filet Mignon"

Solid fourth-quarter earnings get topped off by impressive phase 2 data for the biotech's next-generation cystic fibrosis drugs.

01 февраля, 17:57

Vertex (VRTX) Q4 Earnings Beat on Strong CF Products Sales

Vertex Pharma (VRTX) fourth-quarter earnings increase from the year-ago period led by strong sales of CF drugs and lower operating expenses.

01 февраля, 15:48

Biotech Stock Roundup: AbbVie 4Q Results Impress, Ablynx to be Acquired by Sanofi

While companies like AbbVie (ABBV) were in focus on 4Q earnings results, Ablynx was in the news with the company agreeing to be acquired by French pharma giant, Sanofi.

Выбор редакции
Выбор редакции
Выбор редакции
01 февраля, 00:14

Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market

Vertex Pharmaceuticals has picked two cystic fibrosis drugs to test in combination with its existing CF medicine, Kalydeco, as part of two different three-drug combinations aimed at helping as many as 90% of patients with cystic fibrosis. (Vertex's current offerings can treat half.)

31 января, 14:12

Vertex (VRTX) & Other Drug Stocks with FDA Catalysts this February

Here is a look at Vertex (VRTX) and a few other companies that await a decision from the FDA in February for label expansions or new drugs.